pLKO.1 puro shRNA E-cadherin Citations (9)
Originally described in: Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways.Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, Weinberg RA Cancer Res. 2008 May 15. 68(10):3645-54. PubMed Journal
Articles Citing pLKO.1 puro shRNA E-cadherin
| Articles |
|---|
| DNAJB4 molecular chaperone distinguishes WT from mutant E-cadherin, determining their fate in vitro and in vivo. Simoes-Correia J, Silva DI, Melo S, Figueiredo J, Caldeira J, Pinto MT, Girao H, Pereira P, Seruca R. Hum Mol Genet. 2014 Apr 15;23(8):2094-105. doi: 10.1093/hmg/ddt602. Epub 2013 Nov 29. PubMed |
| Microtubules Inhibit E-Cadherin Adhesive Activity by Maintaining Phosphorylated p120-Catenin in a Colon Carcinoma Cell Model. Maiden SL, Petrova YI, Gumbiner BM. PLoS One. 2016 Feb 4;11(2):e0148574. doi: 10.1371/journal.pone.0148574. eCollection 2016. PubMed |
| Roles for E-cadherin cell surface regulation in cancer. Petrova YI, Schecterson L, Gumbiner BM. Mol Biol Cell. 2016 Nov 1;27(21):3233-3244. Epub 2016 Aug 31. PubMed |
| UNC0638, a G9a inhibitor, suppresses epithelialmesenchymal transitionmediated cellular migration and invasion in triple negative breast cancer. Liu XR, Zhou LH, Hu JX, Liu LM, Wan HP, Zhang XQ. Mol Med Rep. 2018 Feb;17(2):2239-2244. doi: 10.3892/mmr.2017.8190. Epub 2017 Nov 29. PubMed |
| Klf4 reduces stemness phenotype, triggers mesenchymal-epithelial transition (MET)-like molecular changes, and prevents tumor progression in nasopharygeal carcinoma. Li X, Zhao Z, Zhang X, Yang S, Lin X, Yang X, Lin X, Shi J, Wang S, Zhao W, Li J, Gao F, Liu M, Ma N, Luo W, Yao K, Sun Y, Xiao S, Xiao D, Jia J. Oncotarget. 2017 Sep 27;8(55):93924-93941. doi: 10.18632/oncotarget.21370. eCollection 2017 Nov 7. PubMed |
| AIF promotes a JNK1-mediated cadherin switch independently of respiratory chain stabilization. Scott AJ, Walker SA, Krank JJ, Wilkinson AS, Johnson KM, Lewis EM, Wilkinson JC. J Biol Chem. 2018 Sep 21;293(38):14707-14722. doi: 10.1074/jbc.RA118.004022. Epub 2018 Aug 9. PubMed |
| The strong propensity of Cadherin-23 for aggregation inhibits cell migration. Sannigrahi MK, Srinivas CS, Deokate N, Rakshit S. Mol Oncol. 2019 May;13(5):1092-1109. doi: 10.1002/1878-0261.12469. Epub 2019 Mar 19. PubMed |
| p190A RhoGAP induces CDH1 expression and cooperates with E-cadherin to activate LATS kinases and suppress tumor cell growth. Ouyang H, Luong P, Frodin M, Hansen SH. Oncogene. 2020 Aug;39(33):5570-5587. doi: 10.1038/s41388-020-1385-2. Epub 2020 Jul 8. PubMed |
| Epithelial-mesenchymal plasticity determines estrogen receptor positive breast cancer dormancy and epithelial reconversion drives recurrence. Aouad P, Zhang Y, De Martino F, Stibolt C, Ali S, Ambrosini G, Mani SA, Maggs K, Quinn HM, Sflomos G, Brisken C. Nat Commun. 2022 Aug 25;13(1):4975. doi: 10.1038/s41467-022-32523-6. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.